232 related articles for article (PubMed ID: 29708923)
21. PCSK9 R46L, lower LDL, and cardiovascular disease risk in familial hypercholesterolemia: a cross-sectional cohort study.
Saavedra YG; Dufour R; Davignon J; Baass A
Arterioscler Thromb Vasc Biol; 2014 Dec; 34(12):2700-5. PubMed ID: 25278291
[TBL] [Abstract][Full Text] [Related]
22. Inborn coagulation factors are more important cardiovascular risk factors than high LDL-cholesterol in familial hypercholesterolemia.
Ravnskov U; de Lorgeril M; Kendrick M; Diamond DM
Med Hypotheses; 2018 Dec; 121():60-63. PubMed ID: 30396495
[TBL] [Abstract][Full Text] [Related]
23. Predicting Cardiovascular Events in Familial Hypercholesterolemia: The SAFEHEART Registry (Spanish Familial Hypercholesterolemia Cohort Study).
Pérez de Isla L; Alonso R; Mata N; Fernández-Pérez C; Muñiz O; Díaz-Díaz JL; Saltijeral A; Fuentes-Jiménez F; de Andrés R; Zambón D; Piedecausa M; Cepeda JM; Mauri M; Galiana J; Brea Á; Sanchez Muñoz-Torrero JF; Padró T; Argueso R; Miramontes-González JP; Badimón L; Santos RD; Watts GF; Mata P
Circulation; 2017 May; 135(22):2133-2144. PubMed ID: 28275165
[TBL] [Abstract][Full Text] [Related]
24. LPA genotype is associated with premature cardiovascular disease in familial hypercholesterolemia.
Paquette M; Bernard S; Thanassoulis G; Baass A
J Clin Lipidol; 2019; 13(4):627-633.e1. PubMed ID: 31103339
[TBL] [Abstract][Full Text] [Related]
25. Family history and cardiovascular risk in familial hypercholesterolemia: data in more than 1000 children.
Wiegman A; Rodenburg J; de Jongh S; Defesche JC; Bakker HD; Kastelein JJ; Sijbrands EJ
Circulation; 2003 Mar; 107(11):1473-8. PubMed ID: 12654602
[TBL] [Abstract][Full Text] [Related]
26. [Familial hypercholesterolemia].
Windler E; Beil FU; Altenburg C; Rinninger F
Dtsch Med Wochenschr; 2012 Nov; 137(46):2375-9. PubMed ID: 23132157
[TBL] [Abstract][Full Text] [Related]
27. Homozygous familial hypercholesterolemia in childhood: Genotype-phenotype description, established therapies and perspectives.
Sanna C; Stéphenne X; Revencu N; Smets F; Sassolas A; Di Filippo M; Descamps OS; Sokal EM
Atherosclerosis; 2016 Apr; 247():97-104. PubMed ID: 26894473
[TBL] [Abstract][Full Text] [Related]
28. Clinical determinants and treatment gaps in familial hypercholesterolemia: Data from a multi-ethnic regional health service.
Zafrir B; Jubran A; Lavie G; Halon DA; Flugelman MY; Shapira C
Eur J Prev Cardiol; 2017 May; 24(8):867-875. PubMed ID: 28186442
[TBL] [Abstract][Full Text] [Related]
29. Clinical phenotype in relation to the distance-to-index-patient in familial hypercholesterolemia.
Besseling J; Huijgen R; Martin SS; Hutten BA; Kastelein JJ; Hovingh GK
Atherosclerosis; 2016 Mar; 246():1-6. PubMed ID: 26745182
[TBL] [Abstract][Full Text] [Related]
30. TaqIB polymorphism in CETP gene: the influence on incidence of cardiovascular disease in statin-treated patients with familial hypercholesterolemia.
Mohrschladt MF; van der Sman-de Beer F; Hofman MK; van der Krabben M; Westendorp RG; Smelt AH
Eur J Hum Genet; 2005 Jul; 13(7):877-82. PubMed ID: 15856070
[TBL] [Abstract][Full Text] [Related]
31. Long-Term Cardiovascular Risk in Heterozygous Familial Hypercholesterolemia Relatives Identified by Cascade Screening.
Kjærgaard KA; Christiansen MK; Schmidt M; Olsen MS; Jensen HK
J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28652386
[TBL] [Abstract][Full Text] [Related]
32. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
Jensen HK
Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
[TBL] [Abstract][Full Text] [Related]
33. PON2 gene variants are associated with clinical manifestations of cardiovascular disease in familial hypercholesterolemia patients.
Leus FR; Zwart M; Kastelein JJ; Voorbij HA
Atherosclerosis; 2001 Feb; 154(3):641-9. PubMed ID: 11257265
[TBL] [Abstract][Full Text] [Related]
34. Serious flaws in targeting LDL-C reduction in the management of cardiovascular disease in familial hypercholesterolemia.
Ravnskov U; de Lorgeril M; Kendrick M; Diamond DM
Expert Rev Clin Pharmacol; 2021 Mar; 14(3):405-406. PubMed ID: 33565344
[TBL] [Abstract][Full Text] [Related]
35. Identifying familial hypercholesterolemia in acute coronary syndrome.
Gencer B; Nanchen D
Curr Opin Lipidol; 2016 Aug; 27(4):375-81. PubMed ID: 27092769
[TBL] [Abstract][Full Text] [Related]
36. Detecting familial hypercholesterolemia by serum lipid profile screening in a hospital setting: Clinical, genetic and atherosclerotic burden profile.
Scicali R; Di Pino A; Platania R; Purrazzo G; Ferrara V; Giannone A; Urbano F; Filippello A; Rapisarda V; Farruggia E; Piro S; Rabuazzo AM; Purrello F
Nutr Metab Cardiovasc Dis; 2018 Jan; 28(1):35-43. PubMed ID: 28958694
[TBL] [Abstract][Full Text] [Related]
37. Inflammatory Biomarkers for Cardiovascular Risk Stratification in Familial Hypercholesterolemia.
Bahrami A; Liberale L; Reiner Ž; Carbone F; Montecucco F; Sahebkar A
Rev Physiol Biochem Pharmacol; 2020; 177():25-52. PubMed ID: 32691159
[TBL] [Abstract][Full Text] [Related]
38. rs1801275 Interleukin-4 receptor alpha polymorphism in familial hypercholesterolemia.
Sánchez Muñoz-Torrero JF; Rivas MD; Zamorano J; Alonso R; Joya-Vazquez P; Padró T; Mata P
J Clin Lipidol; 2014; 8(4):418-22. PubMed ID: 25110223
[TBL] [Abstract][Full Text] [Related]
39. Familial hypercholesterolemia mutations in the Middle Eastern and North African region: a need for a national registry.
Bamimore MA; Zaid A; Banerjee Y; Al-Sarraf A; Abifadel M; Seidah NG; Al-Waili K; Al-Rasadi K; Awan Z
J Clin Lipidol; 2015; 9(2):187-94. PubMed ID: 25911074
[TBL] [Abstract][Full Text] [Related]
40. Lipoprotein(a) levels in familial hypercholesterolemia: an important predictor of cardiovascular disease independent of the type of LDL receptor mutation.
Alonso R; Andres E; Mata N; Fuentes-Jiménez F; Badimón L; López-Miranda J; Padró T; Muñiz O; Díaz-Díaz JL; Mauri M; Ordovás JM; Mata P;
J Am Coll Cardiol; 2014 May; 63(19):1982-9. PubMed ID: 24632281
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
